Related references
Note: Only part of the references are listed.Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
D. J. A. R. Moes et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation
N. Shuker et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation
Carlos Orlando Jacobo-Cabral et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients
Katalin Monostory et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit
Hylke de Jonge et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Pharmacokinetics and pharmacodynamics of tacrolimus in liver transplant recipients: inside the white blood cells
Florian Lemaitre et al.
CLINICAL BIOCHEMISTRY (2015)
Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients
Christine E. Staatz et al.
CLINICAL PHARMACOKINETICS (2015)
Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients
Louise M. Andrews et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation
Jian-wei Yang et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients
Jing-Jing Zhang et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2015)
Multigene predictors of tacrolimus exposure in kidney transplant recipients
Rebecca A. Pulk et al.
PHARMACOGENOMICS (2015)
Development of a Population PK Model of Tacrolimus for Adaptive Dosage Control in Stable Kidney Transplant Patients
Franc Andreu et al.
THERAPEUTIC DRUG MONITORING (2015)
Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients-A Prospective, Randomized Study
Elisabet Storset et al.
TRANSPLANTATION (2015)
Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients (Publication with Expression of Concern. See vol. 50, pg. 1265, 2020)
LiQin Zhu et al.
XENOBIOTICA (2015)
Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management
Nauras Shuker et al.
TRANSPLANTATION REVIEWS (2015)
A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients
Yan-xia Lu et al.
ACTA PHARMACOLOGICA SINICA (2015)
Population Pharmacokinetic-Pharmacogenetic Model of Tacrolimus in the Early Period after Kidney Transplantation
Nayoung Han et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients
Mariam H. Abdel Jalil et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients
Nastya Kassir et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Exposure to Mycophenolic Acid Better Predicts Immunosuppressive Efficacy Than Exposure to Calcineurin Inhibitors in Renal Transplant Patients
Z. Daher Abdi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Importance of hematocrit for a tacrolimus target concentration strategy
Elisabet Storset et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Total plasma protein effect on tacrolimus elimination in kidney transplant patients - Population pharmacokinetic approach
Bojana Golubovic et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
ABCB1 1199G>A Genetic Polymorphism (Rs2229109) Influences the Intracellular Accumulation of Tacrolimus in HEK293 and K562 Recombinant Cell Lines
Geraldine Dessilly et al.
PLOS ONE (2014)
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach
Vanessa Guy-Viterbo et al.
PHARMACOGENOMICS (2014)
The Population Pharmacokinetic Models of Tacrolimus in Chinese Adult Liver Transplantation Patients
Liqin Zhu et al.
JOURNAL OF PHARMACEUTICS (2014)
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
R. Bouamar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Statistical tools for dose individualization of mycophenolic acid and tacrolimus co-administered during the first month after renal transplantation
Flora T. Musuamba et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools
Aline Fuchs et al.
CLINICAL PHARMACOKINETICS (2013)
Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients
Ken Ogasawara et al.
CLINICAL PHARMACOKINETICS (2013)
Influence of SLCO1B3 Genetic Variations on Tacrolimus Pharmacokinetics in Renal Transplant Recipients
Andree-Anne Bolvin et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children
Wei Zhao et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients
Nayoung Han et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction
Itziar Oteo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients
Wei Zhao et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation
V. Guy-Viterbo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetics of tacrolimus in kidney transplant patients
R. Velickovic-Radovanovic et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Tacrolimus dose individualization in de novo patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology
Naiara Valdivieso et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis
Xiao-cong Zuo et al.
PHARMACOGENETICS AND GENOMICS (2013)
PharmGKB summary: cyclosporine and tacrolimus pathways
Julia M. Barbarino et al.
PHARMACOGENETICS AND GENOMICS (2013)
Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs
Mateusz Kurzawski et al.
PHARMACOGENOMICS (2013)
Lessons From Routine Dose Adjustment of Tacrolimus in Renal Transplant Patients Based on Global Exposure
Franck Saint-Marcoux et al.
THERAPEUTIC DRUG MONITORING (2013)
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
Anders Asberg et al.
TRANSPLANT INTERNATIONAL (2013)
Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs
P. A. Jacobson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Population Pharmacokinetic Modelling and Design of a Bayesian Estimator for Therapeutic Drug Monitoring of Tacrolimus in Lung Transplantation
Caroline Monchaud et al.
CLINICAL PHARMACOKINETICS (2012)
A Simultaneous D-Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation
Flora Tshinanu Musuamba et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Safe and Effective Variability-A Criterion for Dose Individualization
Nicholas H. G. Holford et al.
THERAPEUTIC DRUG MONITORING (2012)
The Impact of Sulfonylureas on Tacrolimus Apparent Clearance Revealed by a Population Pharmacokinetics Analysis in Chinese Adult Liver-Transplant Patients
Xiao-qing Zhang et al.
THERAPEUTIC DRUG MONITORING (2012)
Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients
Katherine A. Barraclough et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf® and once daily Advagraf®
Jean-Baptiste Woillard et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Area Under the Concentration-Time Curve: Is This Clinically Useful for Dosage Prediction Yet?
Christine E. Staatz et al.
CLINICAL PHARMACOKINETICS (2011)
The influence of pharmacogenetics and cofactors on clinical outcomes in kidney transplantation
Nicolas Picard et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation
Francois Glowacki et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Limited Sampling Strategy for Estimating Individual Exposure of Tacrolimus in Pediatric Kidney Transplant Patients
Wei Zhao et al.
THERAPEUTIC DRUG MONITORING (2011)
Population Pharmacokinetics of Tacrolimus in Pediatric Liver Transplantation: Early Posttransplantation Clearance
Johan E. Wallin et al.
THERAPEUTIC DRUG MONITORING (2011)
Large Scale Analysis of Routine Dose Adjustments of Mycophenolate Mofetil Based on Global Exposure in Renal Transplant Patients
Franck Saint-Marcoux et al.
THERAPEUTIC DRUG MONITORING (2011)
Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation
Khaled Benkali et al.
CLINICAL PHARMACOKINETICS (2010)
Reduced C0 Concentrations and Increased Dose Requirements in Renal Allograft Recipients Converted to the Novel Once-Daily Tacrolimus Formulation
Hylke de Jonge et al.
TRANSPLANTATION (2010)
Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation
H. Ekberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
Khaled Benkali et al.
CLINICAL PHARMACOKINETICS (2009)
Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients
W. Zhao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference
Pierre Wallemacq et al.
THERAPEUTIC DRUG MONITORING (2009)
Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant Recipients
Rogier R. Press et al.
THERAPEUTIC DRUG MONITORING (2009)
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation
Eric Thervet et al.
THERAPEUTIC DRUG MONITORING (2008)
Evaluation of limited sampling strategies for tacrolimus
Robert A. M. Op den Buijsch et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients
D. Li et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Comparison of low versus high tacrolimus levels in kidney transplantation: Assessment of efficacy by protocol biopsies
Fernando G. Cosio et al.
TRANSPLANTATION (2007)
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients
Masahide Fukudo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients
Ju Yeun Lee et al.
PHARMACOTHERAPY (2006)
Population pharmacokinetics of tacrolimus in whole blood and plasma in Asian liver transplant patients
WJ Sam et al.
CLINICAL PHARMACOKINETICS (2006)
Beyond cyclosporine: A systematic review of limited sampling strategies for other immunosuppressants
Lillian S. L. Ting et al.
THERAPEUTIC DRUG MONITORING (2006)
Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients
H Zahir et al.
THERAPEUTIC DRUG MONITORING (2005)
Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance
M Antignac et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)
AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients
EM Scholten et al.
KIDNEY INTERNATIONAL (2005)
Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions
C Knoop et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?
DA Hesselink et al.
PHARMACOGENOMICS (2005)
Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies
F Saint-Marcoux et al.
CLINICAL PHARMACOKINETICS (2005)
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation
CE Staatz et al.
CLINICAL PHARMACOKINETICS (2004)
Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids - A prospective study in one hundred de novo renal transplant recipients
DRJ Kuypers et al.
CLINICAL PHARMACOKINETICS (2004)
Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation
CE Staatz et al.
LIVER TRANSPLANTATION (2003)
Forecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantation
M Fukudo et al.
CLINICAL PHARMACOKINETICS (2003)
Tacrolimus - A further update of its use in the management of organ transplantation
LJ Scott et al.
DRUGS (2003)
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients
CE Staatz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants
CE Staatz et al.
TRANSPLANTATION (2001)
Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation
C Staatz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients
R Venkataramanan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Failure of traditional trough levels to predict tacrolimus concentrations
M Macchi-Andanson et al.
THERAPEUTIC DRUG MONITORING (2001)
Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy
MJG Sanchez et al.
CLINICAL PHARMACOKINETICS (2001)
Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients
WJ Sam et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients
KM Wong et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Share Paper
